From: Detection of interacting transcription factors in human tissues using predicted DNA binding affinity
Tissue | # interactions (nonsimilar) | # factors | Top three nonsimilar interactions | Hubs |
---|---|---|---|---|
Bladder* | 3 (3) | 3 | ELK1:NFYA, ELK1:NOBOX, NFYA:NOBOX | - |
Blood | 6 (4) | 5 | SPI1:ARID3A, SPIB:ARID3A, SPI1:CTCF | ARID3A, SPI1, SPIB |
Bone | 24 (24) | 25 | TBP:TFAP2A, TBP:EWSR1-FLI1, TBP:NOBOX | TBP |
Brain | 25 (17) | 20 | SP1:SOX10, SP1:ESR2, SP1:REST | MZF1, SP1 |
Cervix | 40 (30) | 24 | ZFP423:ZFX, ELK1:ZFX, MIZF:ZFX | ZFX, KLF4, ZFP423 |
Eye* | 4 (2) | 6 | T:HNF1B, SP1:TAL1-TCF3 | SP1 |
Heart* | 6 (5) | 7 | MEF2A:MAFB, MEF2A:NFKB1, MEF2A:REST | MEF2A |
Kidney | 95 (87) | 64 | GATA1:HNF1A, HNF1A:ARID3A, TP53:HNF1B | HNF1A, HNF1B |
Liver | 106 (99) | 67 | HNF1A:HNF1B, HNF1A:HNF4A, HNF1A:CEBPA | HNF1A, HNF1B |
Lymph node | 64 (57) | 65 | SPI1:MZF1, SPI1:MYF, SPI1:FOXQ1 | SPI1 |
Muscle | 41 (38) | 40 | MEF2A:ZFP423, MEF2A:NHLH1, MEF2A:NFIC | MEF2A, TBP |
Pancreas* | 14 (13) | 15 | AR:TAL1-GATA1, MZF1:TAL1-GATA1, E2F1:TAL1-GATA1 | TAL1-GATA1 |
Placenta* | 2 (2) | 4 | RREB1:PDX1, ESRRB:POU5F1 | - |
PNS* | 1 (0) | 2 | ELK4:REL | - |
Sm. intestine* | 1 (1) | 2 | NFYA:TBP | - |
Stomach* | 7 (6) | 8 | EWSR1-FLI1:PLAG1, MYC:PLAG1, PAX6:PLAG1 | PLAG1 |
Testis* | 16 (14) | 19 | FOXC1:HOXA5, ARNT-AHR:NOBOX, ARNT-AHR:NKX2-5 | ARNT-AHR |
Tongue* | 12 (11) | 16 | NFKB1:NFIL3, NFKB1:TFAP2A, GATA3:NKX3-1 | NFKB1 |
Adipose** | 104 (90) | 46 | MZF1:NFYA, NFYA:MYB, NFYA:TBP | NFYA, MZF1 |
Lymphocyte** | 181 (156) | 107 | ELK1:CEBPA, ELK1:FOXA2, ELK1:POU5F1 | NFYA, ELK1, GABPA |
Hematop. SC** | 50 (41) | 36 | ELK1:NFYA, NFYA:GABPA, ELK1:EGR1 | NFYA, ELK1 |
Retinal pigm. epithelium** | 259 (219) | 116 | ARNT-AHR:CREB1, ARNT-AHR:NFYA, CREB1:BRCA1 | CREB1, NFYA, PAX2 |